Trial intelligence / Profile preview

Hydrocortisone in Postoperative Neonates with Low Cardiac Output Syndrome

NCT00590018Phase 2Completed

Sponsor
Baylor College of Medicine
Start
Feb 2003
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in low cardiac output syndrome (LCOS) comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Blood Pressure at 2 days. Started Feb 2003; status: completed.

02

Drugs

hydrocortisone
03

Conditions

low cardiac output syndrome (LCOS)

Beyond the preview

Go deeper on NCT00590018.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00590018.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call